Subscribe
Business

Novartis Sandoz unit completes Fougera purchase

By The Associated Press
Published
Add Washington Examiner on Google

Swiss drugmaker Novartis AG’s Sandoz division has completed its $1.53 billion purchase of dermatology drug maker Fougera Pharmaceuticals.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.